FDA Issues Final Cannabis Guidance on Clinical Research
FDA issued its final guidance, Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research. The agency outlines current recommendations for drug sponsors developing cannabis and cannabis-derived compounds for use in human drug clinical research.
Source: natlawreview.com